Skip to content

Motivational Program for Smokers Enrolled in a Methadone Maintenance Program

Smoking Cessation Among Methadone Maintained Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00278226
Enrollment
398
Registered
2006-01-18
Start date
2001-06-30
Completion date
2004-10-31
Last updated
2010-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Keywords

unspecified adult solid tumor, protocol specific

Brief summary

RATIONALE: Stop-smoking programs may help patients stop smoking and prevent cancer from forming. PURPOSE: This clinical trial is studying how well a motivational program works in helping smokers enrolled in a methadone maintenance program quit smoking.

Detailed description

OBJECTIVES: * Determine the efficacy of a brief motivational intervention on smoking cessation in smokers enrolled in a methadone maintenance program. OUTLINE: Patients are assigned to 1 of 2 groups. * Group 1: Patients undergo assessment at baseline and at 1, 3, and 6 months. * Group 2: Patients receive a brief motivational intervention at the time of their baseline assessment and undergo assessment as in group 1. All patients will be offered a 2- to 3-month supply of nicotine patches. PROJECTED ACCRUAL: A total of 400 patients will be accrued for this study.

Interventions

BEHAVIORALsmoking cessation intervention
OTHEReducational intervention

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Butler Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Must be currently enrolled in a methadone maintenance program * Smokes at least 10 cigarettes a day PATIENT CHARACTERISTICS: * Not pregnant * No concurrent medical condition that precludes the use of nicotine patches PRIOR CONCURRENT THERAPY: * No concurrent use of other nicotine replacement therapy

Design outcomes

Primary

MeasureTime frame
Nicotine Abstinence6-months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026